Last reviewed · How we verify
Placebo (acute phase) — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo (acute phase) (Placebo (acute phase)) — ZS Pharma, Inc.. Placebo produces no pharmacological effect and serves as a control comparator in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo (acute phase) TARGET | Placebo (acute phase) | ZS Pharma, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo (acute phase) CI watch — RSS
- Placebo (acute phase) CI watch — Atom
- Placebo (acute phase) CI watch — JSON
- Placebo (acute phase) alone — RSS
Cite this brief
Drug Landscape (2026). Placebo (acute phase) — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-acute-phase. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing